Cover Image
Market Research Report
Product code 
1047090

India Clinical Trial Management Market Forecast 2022-2028

Published: | Inkwood Research | 125 Pages | Delivery time: 2-3 business days

Price

Back to Top
India Clinical Trial Management Market Forecast 2022-2028
Published: January 19, 2022
Inkwood Research
Content info: 125 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The India clinical trial management market is estimated to project a CAGR of 15.07% during the forecast period, 2022-2028. The increasing disease burden, reduced approval period, high population, and online registry contribute to market growth.

MARKET INSIGHTS

The digitalization of clinical trials is expected to drive market growth in India. It has facilitated the streamlining of many clinical trial processes like logistics and supplies management, regulatory compliance, data capture, etc. The launch of digital therapeutics and the ease of real-time data acquisition related to safety & toxicity enables timely rectification in trial design, thereby promoting the market growth.

Furthermore, a significant percentage of the Indian population does not have access to advanced treatment and medicines, given the financial and geographic barriers. As per the Institute for Studies in Industrial Development Report, the country ranks second with regard to patient population for clinical trials. Also, the clinical trials are half-priced from that of Europe and the US. Moreover, the country is also emerging as a top destination for contract research organizations, given its acceptance of international intellectual property rights and guidelines, accessible human resources, low operational costs, availability of a large patient pool, and diverse climatic conditions. Such factors are predicted to influence the growth of the India clinical trial management market.

COMPETITIVE INSIGHTS

Some of the prominent companies in the market are: Parexel International Corporation, Oracle Corporation, ArisIndia LLC, Veeva Systems Inc, Medidata Solutions Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 38434

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 3.2. KEY MARKET TRENDS
  • 3.3. PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1. BUYERS POWER
    • 3.3.2. SUPPLIERS POWER
    • 3.3.3. SUBSTITUTION
    • 3.3.4. NEW ENTRANTS
    • 3.3.5. INDUSTRY RIVALRY
  • 3.4. OPPORTUNITY MATRIX
  • 3.5. VENDOR LANDSCAPE

4. MARKET BY END-USER

  • 4.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 4.2. CLINICAL RESEARCH ORGANIZATIONS
  • 4.3. HEALTHCARE PROVIDERS

5. MARKET BY PRODUCT TYPE

  • 5.1. ENTERPRISE-BASED CTM
  • 5.2. SITE-BASED CTM

6. MARKET BY DEPLOYMENT MODEL

  • 6.1. WEB-BASED DEPLOYMENT
  • 6.2. ON-PREMISE DEPLOYMENT
  • 6.3. CLOUD-BASED DEPLOYMENT

7. MARKET BY COMPONENT

  • 7.1. SOFTWARE
  • 7.2. HARDWARE
  • 7.3. SERVICES

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS
  • 8.2. COMPANY PROFILES
    • 8.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 8.2.2. ARISGLOBAL LLC
    • 8.2.3. BIOCLINICA INC
    • 8.2.4. BIO-OPTRONICS INC
    • 8.2.5. IBM CORPORATION
    • 8.2.6. MEDIDATA SOLUTIONS INC
    • 8.2.7. MEDNET SOLUTIONS INC
    • 8.2.8. ORACLE CORPORATION
    • 8.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 8.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 4: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 6: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 8: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
  • TABLE 10: LIST OF MERGERS & ACQUISITIONS
  • TABLE 11: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
  • TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 13: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: INDIA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 6: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
  • FIGURE 7: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2028 (IN $ MILLION)
  • FIGURE 8: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2028 (IN $ MILLION)
  • FIGURE 9: INDIA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 10: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2028 (IN $ MILLION)
  • FIGURE 11: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2028 (IN $ MILLION)
  • FIGURE 12: INDIA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021
  • FIGURE 13: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2028 (IN $ MILLION)
  • FIGURE 14: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2028 (IN $ MILLION)
  • FIGURE 15: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2028 (IN $ MILLION)
  • FIGURE 16: INDIA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
  • FIGURE 17: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2028 (IN $ MILLION)
  • FIGURE 18: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2028 (IN $ MILLION)
  • FIGURE 19: INDIA CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2028 (IN $ MILLION)